| Literature DB >> 26258480 |
Mariusz Jaskolski1, Maria Miller2, J K Mohana Rao2, Alla Gustchina2, Alexander Wlodawer2.
Abstract
Determinations of only a very few protein structures had consequences comparable to the impact exerted by the structure of the protease encoded by HIV-1, published just over 25 years ago. The structure of this relatively small protein and its cousins from other retroviruses provided a clear target for a spectacularly successful structure-assisted drug design effort that offered new hope for controlling the then-escalating AIDS epidemic. This reminiscence is limited primarily to work conducted at the National Cancer Institute, and is not meant to be a comprehensive history of the field, but is rather an attempt to provide a very personal account of how the structures of this most thoroughly studied crystallographic target were determined. Published 2015. This article is a U.S. Government work and is in the public domain in the USA.Entities:
Keywords: HIV; crystal structures; drug design; inhibitors; protease
Mesh:
Substances:
Year: 2015 PMID: 26258480 PMCID: PMC6310002 DOI: 10.1111/febs.13397
Source DB: PubMed Journal: FEBS J ISSN: 1742-464X Impact factor: 5.542